Detalhe da pesquisa
1.
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
Br J Cancer
; 128(4): 549-555, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434154
2.
[18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study.
J Nucl Med
; 65(2): 185-191, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164579
3.
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.
J Nucl Med
; 65(2): 236-244, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164576
4.
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera.
EJNMMI Phys
; 10(1): 64, 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853247